These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8701191)

  • 1. [Therapy-oriented assessment of heart failure in the hospital and clinical practice].
    Mohacsi P; Graetz G
    Praxis (Bern 1994); 1996 Feb; 85(8):245-55. PubMed ID: 8701191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine levels and treatment in chronic heart failure.
    Anker SD
    Eur Heart J; 1998 Jun; 19 Suppl F():F56-61. PubMed ID: 9651737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between myocardial remodeling and neurohumoral activation in patients with cardiac failure].
    Vizir VA; Berezin AE
    Klin Med (Mosk); 2001; 79(9):21-7. PubMed ID: 11641931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic heart failure as a metabolic disorder.
    Anker SD; Al-Nasser FO
    Heart Fail Monit; 2000; 1(2):42-9. PubMed ID: 12634873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of neuroendocrine parameters in heart failure].
    Pacher R
    Wien Med Wochenschr; 1998; 148(5):121-4. PubMed ID: 9654697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of congestive heart failure in the elderly: emphasis on renal functional changes and impact of therapy.
    Chau WL; Burnett JC
    Coron Artery Dis; 1997; 8(8-9):505-9. PubMed ID: 9431478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of heart failure--value of drug therapy].
    Felix SB
    Z Kardiol; 1996; 85 Suppl 4():1-7. PubMed ID: 9027102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute recognition and management of congestive heart failure.
    Passmore JM; Goldstein RA
    Crit Care Clin; 1989 Jul; 5(3):497-532. PubMed ID: 2670091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of heart failure. I. Definition, pathophysiology, therapy of acute heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):30-4. PubMed ID: 9280746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure: neurohumoral approach to treatment].
    Ceia F; Vicente L
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II7-16. PubMed ID: 11301912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of heart failure. II. Therapy of chronic heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):36-8, 41-5. PubMed ID: 9280747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of diastolic dysfunction and heart failure.
    Satpathy C; Mishra TK; Satpathy R; Satpathy HK; Barone E
    Am Fam Physician; 2006 Mar; 73(5):841-6. PubMed ID: 16529092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diastolic heart failure. Pathophysiology, diagnosis and therapy].
    von Scheidt W
    Med Klin (Munich); 1996 Jan; 91(1):28-35. PubMed ID: 8839198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.